REFERENCES
- Akashiba T, Otsuka K, Yoshizawa T, et al. Effects of nasal continuous positive airway pressure (NCPAP) on nocturnal renal function in obstructive sleep apnea syndrome (OSAS). Nippon Kyobu Shikkan Gakkai Zasshi 1991; 29: 573–577.
- Gislason T, Almqvist M, Eriksson G, Taube A, Boman G. Prevalence of sleep apnea syndrome among Swedish men—an epidemiologic study. J Clin Epidemiol 1988; 41: 571–576.
- Guilleminault C, van der Hoed J, Mitler M. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement W. eds. Sleep apnea syndromes New York: AR Liss, 1978: 1–12.
- Krieger J. Mechanisms of daytime pulmonary hypertension and altered renal function in obstructive sleep apnea. In: Guilleminault C, Partinen M. eds. Obstructive sleep apnea syndrome. Clinical research and treatment. New York: Raven Press 1990; 71–79.
- Lowe AA. Dental applications for the treatment of snoring and obstructive sleep apnea. In: Kryger MH, Roth T, Dement W. eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders 1994: 722–735.
- Podszus T, Bauer W, Mayer J, Penzel T, Peter JH, von Wichert P. Sleep apnea and pulmonary hypertension. Klin Wochenschr 1986; 64: 131–134.
- Rodriguez BE. Nocturia as the leading symptom in the sleep apnea syndrome (letter). Med Clin (Barc) 1990; 95: 793.
- Sullivan C, Berthon-Jones M, Issa F, Evers L. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862–865.
- Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–1235.